Pharmaceutical Technology on MSN
CSL and Alentis ink $1.5bn partnership to progress antifibrotic drug
The pair will work together to progress lixudebart across multiple rare kidney and liver diseases.
Accordingto Bank of America Securities' initial coverage report, AP301's revenue in the Chinese market could reach ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
9月29日，华泰证券围绕IgA肾病治疗格局举办的电话会，将礼邦医药(09637.HK)AP308的差异化机制放到投资者面前：直接降解已经形成的IgA及其免疫复合物，探索清除肾小球内已有沉积。为什么AP308这条仍待人体验证的管线值得关注？答案要从近期肾脏病创新药的变化中寻找。 截至10月6日收盘，礼邦医药报26.66港元，录得五连涨，较9月28日收盘累计上涨13.7%。按9月14日23港元的阶段收 ...
美銀證券首次覆蓋報告預計，按風險調整前、扣除分銷等相關成本的口徑，AP301在2035年中國市場收入可達約29.7億元人民幣。9月29日，華泰證券圍繞IgA腎病治療格局舉辦的電話會，將禮邦醫藥(09637.HK)AP308的差異化機制放到投資者面前： ...
Årets Lexington Selected Yearling Sale fik en forrygende start, men en samlet fremgang i gennemsnitsomsætningen på 10%, og hvor de 38 travhingste solgtes for en gennemsnitspris der var ikke mindre ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results